Evaluation of palatability of newly developed fast disintegrating tablet of Kremezin in patient.
Not Applicable
- Conditions
- Chronic renal failure
- Registration Number
- JPRN-UMIN000031986
- Lead Sponsor
- School of Pharmaceutical Sciences University of Shizuoka
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who apply to administration contraindications in the package insert of kremezin Patients who will not see the outpatients clinic within 2 weeks to 2 months Patients who can not communicate due to cognitive deterioration Patients who do not manage medication by themselves and their families Patients who it is hard to swallow Patients who have extraordinary state in oral cavity. Patients who is considered as imappropriate by doctor.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method